Andrew Chia

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Andrew Y. Chia, PharmD, MS, was a Program Director, Regulatory Oncology/Hematology at Genentech, San Francisco area, CA. He has conducted research with his father, John Chia, on enteroviruses and ME/CFS. He is a Senior Director, Regulatory Oncology at Gilead Sciences, Inc.

Dr Chia developed chronic fatigue syndrome in 1997 while in high school, following a severe respiratory infection and pneumonia. He credits his recovery to the immunomodulator Interferon and the Chinese herb, Sophora Flavescens contained in a dietary supplement product called Equilibrant.[1]

Notable studies[edit | edit source]

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. "Infectious disease specialist Dr. Chia Treats Chronic Fatigue Syndrome". Health Rising. Retrieved December 13, 2018.
  2. Chia, John K.; Chia, Andrew Y.; Wang, David; El-Habbal, Rabiha (2015), "Functional Dyspepsia and Chronic Gastritis Associated with Enteroviruses", Open Journal of Gastroenterology, 5 (4): 21-27., doi:10.4236/ojgas.2015.54005
  3. Chia, John; Chia, Andrew (2008). "Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach". Journal of Clinical Pathology. 61 (1): 43–48.
  4. Chia, John K; Chia, Andrew (2004). "Ribavirin and Interferon-α for the Treatment of Patients with Chronic Fatigue Syndrome Associated with Persistent Coxsackievirus B Infection: A Preliminary Observation" (PDF). The Journal of Applied Research. 4 (2): 286–292.